Fifth Lane Capital, LP Horizon Therapeutics Public LTD CO Call Options Transaction History

Fifth Lane Capital, LP

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 14, 2023	BUY	$98.98 - $115.74 $3.99 Million - $4.66 Million	40,300 Added 14.36%	321,000 $37.1 Million
Q2 2023 Aug 03, 2023	BUY	$96.34 - $112.38 $27 Million - $31.5 Million	280,700 New	280,700 $28.9 Million
Q1 2023 May 15, 2023	SELL	$107.32 - $113.5 $4.04 Million - $4.27 Million	-37,600 Closed	0 $0
Q4 2022 Feb 14, 2023	BUY	$62.39 - $113.8 $2.35 Million - $4.28 Million	37,600 New	37,600 $4.28 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Fifth Lane Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Fifth Lane Capital, LP with notifications on news.